Wolverine Trading, LLC Teva Pharmaceutical Industries LTD Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $490,110 - $587,760	31,000 Added 37.35%	114,000 $2.05 Million
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $2.91 Million - $3.97 Million	-228,000 Reduced 73.31%	83,000 $1.35 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $440,671 - $595,959	41,300 Added 15.31%	311,000 $4.39 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $1.18 Million - $1.55 Million	-145,400 Reduced 35.03%	269,700 $2.82 Million
Q3 2023 Nov 15, 2023	BUY	$7.48 - $10.7 $691,900 - $989,749	92,500 Added 28.67%	415,100 $4.23 Million
Q2 2023 Aug 23, 2023	SELL	$7.2 - $9.47 $1.12 Million - $1.47 Million	-155,400 Reduced 32.51%	322,600 $2.43 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $916,255 - $1.25 Million	109,600 Added 29.75%	478,000 $4.22 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $1.77 Million - $2.11 Million	222,300 Added 152.16%	368,400 $3.36 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $613,284 - $1.07 Million	-89,400 Reduced 37.96%	146,100 $1.14 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $150,552 - $212,160	20,400 Added 9.48%	235,500 $1.87 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $860,542 - $1.1 Million	-117,400 Reduced 35.31%	215,100 $2.02 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $389,470 - $502,367	49,300 Added 17.41%	332,500 $2.63 Million
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $203,634 - $247,374	24,300 Added 9.39%	283,200 $2.82 Million
Q2 2021 Aug 06, 2021	BUY	$9.9 - $11.56 $467,280 - $545,632	47,200 Added 22.3%	258,900 $2.6 Million
Q1 2021 May 14, 2021	SELL	$10.34 - $12.81 $1.84 Million - $2.28 Million	-178,100 Reduced 45.69%	211,700 $2.4 Million
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $476,132 - $610,512	55,300 Added 16.53%	389,800 $3.74 Million
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $168,829 - $249,993	19,700 Added 6.26%	334,500 $2.96 Million
Q2 2020 Aug 13, 2020	SELL	$8.12 - $13.12 $2.21 Million - $3.58 Million	-272,500 Reduced 46.4%	314,800 $3.83 Million
Q1 2020 May 11, 2020	SELL	$6.69 - $13.45 $2.7 Million - $5.42 Million	-403,200 Reduced 40.71%	587,300 $5 Million
Q4 2019 Feb 12, 2020	BUY	$6.53 - $10.72 $4.72 Million - $7.76 Million	723,500 Added 270.97%	990,500 $9.63 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $78,848 - $122,880	-12,800 Reduced 4.57%	267,000 $1.85 Million
Q2 2019 Aug 20, 2019	SELL	$8.12 - $15.72 $558,656 - $1.08 Million	-68,800 Reduced 19.74%	279,800 $2.58 Million
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $148,010 - $190,095	9,500 Added 2.8%	348,600 $5.47 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $408,520 - $667,520	-28,000 Reduced 7.63%	339,100 $5.32 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $3.41 Million - $4.15 Million	161,700 Added 78.72%	367,100 $7.91 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $3.43 Million - $4.53 Million	205,400 New	205,400 $3.51 Million
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $3.53 Million - $6.01 Million	-314,400 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$15.41 - $32.17 $4.84 Million - $10.1 Million	314,400	314,400 $5.53 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$972 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$820 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$781 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$652 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$600 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account